1 | (S)-Warfarin | S-warfarin 1件: S-warfarin; | - |
- |
- |
013 1件: 13 💬 |
2 | Abatacept | Abatacept 36件: Abatacept; Abatacept (aba); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (ctla4-ig); Abatacept (iv); Abatacept (sc); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept active treatment; Abatacept delayed-onset treatment; Abatacept injection; Abatacept placebo; Abatacept prefilled syringe; Abatacept sc; Abatacept subcutaneous; Abatacept, rituximab or tocilizumab; Adalimuab, etanercept, tocilizumab, or abatacept; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Bms 188667 (abatacept); Decrease tocilizumab, abatacept; Device: abatacept combination product (acp); Double-blind abatacept; Drug: abatacept; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Orencia® (abatacept); Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; | 1件: D03203 D03203 💬 |
2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
3 | ABX-1431 | Abx-1431 2件: Abx-1431; Abx-1431 hcl; | - |
- |
- |
013 1件: 13 💬 |
4 | Acetaminophen | Acetaminophen 9件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen tablets; Acetaminophen/paracetamol; Multi-modal pain management [acetaminophen + gabapentin]; Oxycodone/acetaminophen; Paracetamol (acetaminophen); Tramadol /acetaminophen; Tramadol hydrochloride + acetaminophen; | 1件: D00217 D00217 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 16件: 3 , 6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
5 | Acetate | 11c-acetate 98件: 11c-acetate; 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester; 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Abiraterone acetate; Acetate; Bazedoxifene acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Caspofungin acetate; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Cosyntropin acetate; Cyclophosphamide/glatiramer acetate; Delmitide acetate; Depot leuprolide acetate 3.75 mg; Desmopressin acetate; Desmopressin acetate trihydrate; Device: cellulose acetate with petrolatum; Dichloroacetate; Dichloroacetate sodium; Dirucotide acetate; Edratide acetate; Etiprednol dicloacetate; Experimental glatiramer acetate; Flecainide acetate; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Gonadorelin acetate and triptorelin acetate; Human interferon beta-1a and glatiramer acetate; Hydrocortisone acetate; Hydrocortisone sodium acetate; L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lanreotide acetate; Lapaquistat acetate and current lipid-lowering treatment; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate; Leuprorelin acetate 3.75mg injection; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Macimorelin acetate; Megestrol acetate; Megestrol acetate tablet; Methylprednisolone acetate; Nomegestrol acetate; Octreotide acetate; Oxaloacetate (oaa); Phosphate and betamethasone acetate, 2 ml.; Plovamer acetate; Plovamer acetate 0.5 milligram (mg); Plovamer acetate 10 mg; Plovamer acetate 20 mg; Plovamer acetate 3 mg; Prednisolone acetate; Prednisone acetate; Prednisone acetate tablets; Procedure: warm compress prior to injection of glatiramer acetate; Sodium acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Sotrastaurin (inn) acetate; Tetracosactide acetate; Tetracosactide hexaacetate; Tocopherol acetate; Tocopheryl acetate; Triptorelin acetate and gonadorelin acetate; Ulipristal acetate; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zuretinol acetate; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; | - |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
6 | Acetazolamide | Acetazolamide 2件: Acetazolamide; Acetazolamide sandoz 250; | 2件: D00218 D00218
D01196 D01196 💬 |
13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion 7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 7件: 13, 86, 90, 115, 155, 225, 230 💬 |
7 | Acetic acid C-11 | - | - |
- |
- |
013 3件: 13, 86, 88 💬 |
8 | Acetylcysteine | Acetylcysteine 12件: Acetylcysteine; Acetylcysteine effervescent tablets; Acetylcysteine sodium; Fluimucil (acetylcysteine); Glatiramer acetate, n-acetylcysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetylcysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); | 1件: D00221 D00221 💬 |
- |
- |
006 17件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 90, 94, 111, 164, 193, 233, 298, 299 💬 |
9 | Acetylsalicylic acid | Acetylsalicylic acid 2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,; | 1件: D00109 D00109 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬 |
10 | Acyclovir | Acyclovir 1件: Acyclovir; | 1件: D00222 D00222 💬 |
- |
- |
013 5件: 13, 28, 46, 53, 60 💬 |
11 | Adenosine | 2-cda, 2-chloro-2'-deoxy-beta-d-adenosine 19件: 2-cda, 2-chloro-2'-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2'-deoxy-ß-d-adenosine; 2-cda, 2-chloro-2?-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2?-deoxy-ß-d-adenosine; 2-cda, 2-chloro-2’-deoxy-beta-d-adenosine; 2-cda, 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2'-deoxy-beta-d-adenosine (2-cda); 2-chloro-2'-deoxy-ß-d-adenosine (2-cda); 2-chloro-2'-deoxyadenosine (2-cda); 2-chloro-2'-deoxyadenosine, 2cda; 2-chloro-2?-deoxy-beta-d-adenosine; 2-chloro-2?-deoxy-ß-d-adenosine; 2-chloro-2’-deoxy-beta-d-adenosine; 2-chloro-2’-deoxy-beta-d-adenosine (2-cda); 2-chloro-2’-deoxy-ß-d-adenosine; 2-chloro-2’-deoxy-ß-d-adenosine (2-cda); 2-chloro-2’-deoxyadenosine (2-cda); Adenosine; Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv); | 1件: D00045 D00045 💬 |
4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 3件: 13, 58, 65 💬 |
12 | Alanine | 3-(3,4-dihydroxyphenyl)-l-alanine 7件: 3-(3,4-dihydroxyphenyl)-l-alanine; Alanine; Benzoyl-l-tyrosyl-[1-13c]alanine (bz-tyr-ala); Beta-alanine; Beta-alanine supplementation; L-3-(3,4-dihydroxyphenyl)alanine; L-alanine; | 1件: D00012 D00012 💬 |
- |
- |
006 4件: 6 , 13, 298, 299 💬 |
13 | Alemtuzumab | Alemtuzumab 20件: Alemtuzumab; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab (campath); Alemtuzumab (gz402673); Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab and rituximab; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection; Alemtuzumab injection [lemtrada]; Alemtuzumab, rituximab; Campath-1h (alemtuzumab); Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; | 1件: D02802 D02802 💬 |
- |
- |
013 21件: 13, 15, 19, 20, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬 |
14 | Alfuzosin | Alfuzosin 1件: Alfuzosin; | 2件: D01692 D01692
D07124 D07124 💬 |
1件: ADRA1A 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
15 | Amantadine | 240mg amantadine hcl er tablets 13件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hcl extended release capsule; Amantadine hydrochloride; Amantadine hydrochloride (hcl); Amantadine sulfate; Determination of drug effects through amantadine cessation; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj; | 2件: D00777 D00777
D07441 D07441 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6 , 8 , 13, 127 💬 |
16 | Amiloride | Amiloride 6件: Amiloride; Amiloride hcl; Amiloride hydrochloride; Amiloride hydrochloride, 2 h2o; Amiloride solution for inhalation; Hydrochlorothiazide/amiloride; | 2件: D00649 D00649
D07447 D07447 💬 |
3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 3件: 13, 225, 299 💬 |
17 | Aminosalicylic acid | -aminosalicylic acid 10件: -aminosalicylic acid; 4-aminosalicylic acid; 4-aminosalicylic acid extended release granules; 5-aminosalicylic acid; 5-aminosalicylic acid (5-asa); 5-aminosalicylic acid(5-asa) and/or prednisone; Aminosalicylic acid; Mesalamine, 5-aminosalicylic acid; Mesalamine, 5-aminosalicylic acid [5-asa]; Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa); | 1件: D00162 D00162 💬 |
- |
- |
013 3件: 13, 96, 97 💬 |
18 | Amlodipine | Amlodipine 3件: Amlodipine; Amlodipine (drug); Amlodipine gel; | 3件: D00615 D00615
D02914 D02914
D07450 D07450 💬 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 4件: 13, 51, 67, 298 💬 |
19 | Ampicillin | - | 3件: D00204 D00204
D01251 D01251
D02119 D02119 💬 |
- |
- |
002 5件: 2 , 6 , 13, 84, 299 💬 |
20 | Anakinra | Anakinra 8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra / kineret; Anakinra and peg stnf-r1; Kineret® (anakinra); Kineret® or anakinra; Response to anakinra associated with methotrexate; | 1件: D02934 D02934 💬 |
2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
21 | Antithymocyte immunoglobulin (rabbit) | - | - |
- |
- |
013 9件: 13, 36, 49, 51, 60, 65, 96, 285, 326 💬 |
22 | Arbaclofen | Arbaclofen 7件: Arbaclofen; Arbaclofen er tablets; Arbaclofen extended release tablets; Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid; | 1件: D09791 D09791 💬 |
2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 2件: 13, 206 💬 |
23 | Arbaclofen Placarbil | Arbaclofen placarbil 4件: Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid; | 1件: D08861 D08861 💬 |
2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
24 | Armodafinil | Armodafinil 1件: Armodafinil; | 1件: D03215 D03215 💬 |
1件: SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 3件: 6 , 13, 84 💬 |
25 | Aspartame | - | 1件: D02381 D02381 💬 |
2件: TAS1R2, TAS1R3 💬 |
Carbohydrate digestion and absorption 2件: Carbohydrate digestion and absorption, Taste transduction |
006 5件: 6 , 13, 67, 86, 230 💬 |
26 | Atacicept | Atacicept 9件: Atacicept; Atacicept 150 mg; Atacicept 25 mg; Atacicept 75 mg; Atacicept 75 milligram (mg); Atacicept150mg; Atacicept25mg; Atacicept75mg; Atacicept: with loading dose; | 1件: D09704 D09704 💬 |
2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 49, 66 💬 |
27 | ATL1102 | Atl1102 1件: Atl1102; | - |
- |
- |
013 1件: 13 💬 |
28 | Atomoxetine | Atomoxetine 1件: Atomoxetine; | 2件: D02574 D02574
D07473 D07473 💬 |
1件: SLC6A2 💬 |
Synaptic vesicle cycle 1件: Synaptic vesicle cycle |
006 3件: 6 , 8 , 13 💬 |
29 | Atorvastatin | Atorvastatin 9件: Atorvastatin; Atorvastatin 10mg; Atorvastatin 20mg; Atorvastatin calcium; Atorvastatin tablet 20 mg; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Lisinopril, losartan, and atorvastatin; Untreated to atorvastatin treatment; | 3件: D00258 D00258
D00887 D00887
D07474 D07474 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
30 | Azathioprine | Azathioprine 38件: Azathioprine; Azathioprine (aza); Azathioprine (aza) caps; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine (imuran) 50 mg overencapsulated tablet; Azathioprine - ratiopharm 50 mg; Azathioprine / 6 mercaptopurine; Azathioprine 25 mg; Azathioprine and allopurinol; Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine or mycophenolate mofetil; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Azathioprine/prednisone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Continuation of azathioprine; Corticosteroid and azathioprine; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Early immunosuppressants (azathioprine, methotrexate); Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Overencapsulated azathioprine (imuran) 50 mg tablet; Prednisone - azathioprine; Products containing azathioprine or 6-mercaptopurine; Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); | 2件: D00238 D00238
D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
31 | Azithromycin | Azithromycin 14件: Azithromycin; Azithromycin (zitromax°); Azithromycin + metronidazole; Azithromycin + n-acetylcystein + inhaled corticosteroid; Azithromycin 250 mg tablets; Azithromycin 250mg capsule; Azithromycin 500 mg film-coated tablet; Azithromycin dihydrate; Azithromycin monohydrate; Azithromycine; Azithromycine 250 mg; Po azithromycin; Rifampin and azithromycin.; Study medication, azithromycin; | 3件: D02134 D02134
D06390 D06390
D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
32 | Baclofen | Aert, (r)-baclofen 20件: Aert, (r)-baclofen; Arbaclofen; Arbaclofen er tablets; Arbaclofen extended release tablets; Arbaclofen placarbil; Arbaclofen placarbil 15 mg bid; Arbaclofen placarbil 30 mg bid; Arbaclofen placarbil 45 mg bid; Baclofen; Baclofen 20 mg; Baclofen er capsules (grs) 10 mg; Baclofen er capsules (grs) 20 mg; Baclofen er capsules (grs) 30mg; Baclofen er capsules (grs) 40mg; Baclofen er capsules (grs) 50 mg; Baclofen ir; Baclofen tablets usp; Baclofen tablets usp 10 mg; Encapsulated baclofen 20 mg; Rs-baclofen; | 1件: D00241 D00241 💬 |
2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 5件: 2 , 10, 13, 18, 149 💬 |
33 | Baminercept | Baminercept 3件: Baminercept; Baminercept alfa; Baminercept alfa (bg9924); | 1件: D08866 D08866 💬 |
1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
34 | Bazedoxifene | Bazedoxifene 2件: Bazedoxifene; Bazedoxifene acetate; | 1件: D03062 D03062 💬 |
- |
- |
013 1件: 13 💬 |
35 | Beta carotene | Beta carotene 2件: Beta carotene; Beta carotene from dunaliella algae; | 1件: D03101 D03101 💬 |
- |
- |
013 2件: 13, 96 💬 |
36 | beta-Alanine | Beta-alanine 2件: Beta-alanine; Beta-alanine supplementation; | 1件: D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
37 | Bevacizumab | Bevacizumab 5件: Bevacizumab; Bevacizumab (avastin) and imatinib mesylate (gleevec); Bevacizumab (genitical recombination); Diagnostic test: pet-ct imaging with [89zr]-bevacizumab; Submucosal bevacizumab; | 1件: D06409 D06409 💬 |
1件: VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
38 | Bexarotene | Bexarotene 1件: Bexarotene; | 1件: D03106 D03106 💬 |
3件: RXRA, RXRB, RXRG 💬 |
Adipocytokine signaling pathway 15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
013 2件: 13, 75 💬 |
39 | Biotin | Biotin 7件: Biotin; Biotina; D-biotin; D-biotina; High doses of thiamine y biotin; Moderate doses of thiamine y biotin; Prebiotics (prebiotin prebiotic fiber stick pac); | 1件: D00029 D00029 💬 |
- |
- |
002 5件: 2 , 8 , 10, 13, 20 💬 |
40 | Bisacodyl | Bisacodyl 1件: Bisacodyl; | 1件: D00245 D00245 💬 |
- |
- |
013 1件: 13 💬 |
41 | Borage oil | Borage oil 2件: Borage oil; Borage oil 20% gla; | - |
- |
- |
013 1件: 13 💬 |
42 | Bortezomib | Bortezomib 8件: Bortezomib; Bortezomib (velcade®); Bortezomib/dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Combination of a single dose anti-cd20 antibody and bortezomib; Cyclophosphamide, bortezomib, and dexamethasone (cybord); Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; | 1件: D03150 D03150 💬 |
1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
43 | Bosentan | Bosentan 18件: Bosentan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan administration; Bosentan and sildenafil; Bosentan group; Bosentan monohidrato; Bosentan monohydrat; Bosentan monohydrate; Bosentan mylan; Bosentan, ambrisentan; Device: nirs after bosentan administration; Device: tcd after bosentan administration; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil 20mg and bosentan 62.5mg; Sildenafil singly or in association with bosentan; | 2件: D01227 D01227
D07538 D07538 💬 |
2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
44 | Botulinum toxin type A | Botulinum toxin type a 6件: Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Botulinum toxin type a 200u; Botulinum toxin type a 300u; Botulinum toxin type a infiltrations; Clostridium botulinum toxin type a; | 1件: D00783 D00783 💬 |
1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 13件: 2 , 5 , 6 , 7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬 |
45 | Brimonidine | 100 µg brimonidine tartrate implant 6件: 100 µg brimonidine tartrate implant; 200 µg brimonidine tartrate implant; 400 µg brimonidine tartrate implant; Brimonidine; Brimonidine tartrate; Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system; | 2件: D02076 D02076
D07540 D07540 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
46 | Caffeine | Caffeine 6件: Caffeine; Caffeine 100 mg; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Other: caffeine; | 2件: D00528 D00528
D01453 D01453 💬 |
11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
47 | Calcium | Amorphous calcium carbonate 34件: Amorphous calcium carbonate; Ascal(r) / carbasalate calcium; Atorvastatin calcium; Calcitriol & calcium; Calcium; Calcium and cholecalciferol; Calcium and vitamin d combination; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Calcium channel blockers; Calcium citrate; Calcium citrate with vitamin d2; Calcium gluconate; Calcium lactate; Calcium levofolinate; Calcium rosuvastatin; Calcium, dietary; Carbasalate calcium; Crestor tablets (calcium rosuvastatin) film-coated tablets; Crystalline calcium supplements; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Low molecular weight heparin calcium injection; Other: calcium stable isotope; Other: determination of calcium intake by a dietician interview; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; Other: serum calcium concentrations results; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Vidofludimus calcium; Vidofludimus calcium dihydrate; | - |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
48 | Calcium carbonate | Amorphous calcium carbonate 6件: Amorphous calcium carbonate; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; | 2件: D00932 D00932
D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
49 | Cannabidiol | Avcn583601 (3% cannabidiol cream) 11件: Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); | 1件: D10915 D10915 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 19件: 2 , 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
50 | Carbamazepine | Carbamazepine 2件: Carbamazepine; Drug-carbamazepine (tegretol xr); | 1件: D00252 D00252 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 2件: 13, 231 💬 |
51 | Carbidopa | Accordion pill carbidopa/levodopa 85件: Accordion pill carbidopa/levodopa; Accordion pill ¿ carbidopa/levodopa 50/400 mg; Accordion pill ¿ carbidopa/levodopa 50/500 mg; Accordion pill? carbidopa/levodopa 50/400 mg; Accordion pill? carbidopa/levodopa 50/500 mg; Accordion pill™ carbidopa/levodopa; Accordion pill™ carbidopa/levodopa 50/400 mg; Accordion pill™ carbidopa/levodopa 50/500 mg; Anhydrous carbidopa; Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg); Carbidopa; Carbidopa (fu); Carbidopa 20 mg; Carbidopa 200mg oral dose; Carbidopa 27.5 mg; Carbidopa 65 mg capsule; Carbidopa and levodopa 25mg/100mg; Carbidopa and levodopa tablets, usp; Carbidopa anidra; Carbidopa fu; Carbidopa inn; Carbidopa levodopa; Carbidopa monohydrate; Carbidopa, levodopa, entacapone; Carbidopa- levodopa; Carbidopa-4'-monophosphate; Carbidopa-levodopa; Carbidopa-levodopa 25 mg-100 mg oral tablet; Carbidopa/l-dopa; Carbidopa/l-dopa/entacapone; Carbidopa/levodopa; Carbidopa/levodopa, immediate release; Carbidopa/levodopa/entacapone; Carbidopamonohydraat; Combination product: l-dopa 70mg/carbidopa 7mg; Comparator: carbidopa; Continuous intrajejunal infusion of levodopa-carbidopa; Controlled-release levodopa / carbidopa; Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel; Entacapone and carbidopa; Foscarbidopa; Foscarbidopa and foslevodopa; Immediate release carbidopa/levodopa; Immediate release carbidopa/levodopa 10/100 mg; Immediate release carbidopa/levodopa 25/100 mg; Ir cd-ld (carbidopa-levodopa) tablets; Levodopa and carbidopa; Levodopa and carbidopa sc solution; Levodopa and carbidopa solution for sc administration; Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa carbidopa intestinal gel (lcig); Levodopa, carbidopa, entacapone; Levodopa, carbidopa, odm-104; Levodopa-carbidopa; Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets; Levodopa-carbidopa immediate release (lc-ir) tablets; Levodopa-carbidopa intestinal gel; Levodopa-carbidopa intestinal gel (lcig); Levodopa-carbidopa multilayer extended release tablet; Levodopa-carbidopa xl tablet (m); Levodopa-carbidopa-entacapone; Levodopa/carbidopa; Levodopa/carbidopa (4:1); Levodopa/carbidopa (ld/cd); Levodopa/carbidopa (sinemet); Levodopa/carbidopa 100/25; Levodopa/carbidopa hydrate; Levodopa/carbidopa solution; Levodopa/carbidopa(200mg/50mg); Levodopa/carbidopa/entacapone; Nd0612 (levodopa/carbidopa solution); Odm-101 105mg carbidopa; Odm-101 65mg carbidopa; Oral levodopa and carbidopa; Oral levodopa/carbidopa; Sinemet (carbidopa/levodopa); Sinemet (levodopa/carbidopa); Sinemet plus (levodopa/carbidopa); Sinemet® controlled release (carbidopa/levodopa); Stalevo (levodopa/ carbidopa/ entacapone); Stalevo (levodopa/carbidopa/entacapona); Stalevo (levodopa/carbidopa/entacapone); Wd-1603 carbidopa and levodopa extended-release tablets; Wd-1603 carbidopa/levodopa extended-release tablets; Xp21279 and carbidopa (experimental); | 1件: D00558 D00558 💬 |
1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
52 | Carbon monoxide | Carbon monoxide 3件: Carbon monoxide; Inhaled carbon monoxide; Other: carbon monoxide-bubbled mediums; | 1件: D09706 D09706 💬 |
- |
- |
006 7件: 6 , 13, 53, 70, 85, 86, 298 💬 |
53 | Carbonate ion | - | - |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
54 | Carmustine | Carmustine 2件: Carmustine; Carmustine, etoposide, cytarabine, and melphalan (beam); | 1件: D00254 D00254 💬 |
- |
- |
011 5件: 11, 13, 14, 28, 60 💬 |
55 | Carnosine | Carnosine 3件: Carnosine; Carnosine supplementation; Carnosine, capsulle, 2 g/day, 8 weeks; | - |
- |
- |
006 2件: 6 , 13 💬 |
56 | CDP323 | Cdp323 1件: Cdp323; | - |
- |
- |
013 1件: 13 💬 |
57 | Ceralifimod | Ceralifimod 1件: Ceralifimod; | - |
- |
- |
013 1件: 13 💬 |
58 | Cetirizine | Antihistamine (cetirizine or equivalent) 4件: Antihistamine (cetirizine or equivalent); Cetirizine; Cetirizine hydrochloride; Glatiramer acetate injection with oral cetirizine hydrochloride; | 2件: D00664 D00664
D07662 D07662 💬 |
1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 2件: 13, 35 💬 |
59 | Chloride ion | - | - |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
60 | Chlormezanone | - | 1件: D00268 D00268 💬 |
- |
- |
013 1件: 13 💬 |
61 | Cholecalciferol | 5000 iu of cholecalciferol 11件: 5000 iu of cholecalciferol; Calcium and cholecalciferol; Cholecalciferol; Cholecalciferol (vitamin d3); Cholecalciferol (vitamind3); Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol and c. xanthorrhiza; Cholecalciferol concentrate; Cholecalciferol concentrate (water-dispersible form); Cholecalciferol, vitamin d3; | 1件: D00188 D00188 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬 |
62 | Cholestyramine | Cholestyramine 1件: Cholestyramine; | - |
- |
- |
013 3件: 13, 79, 254 💬 |
63 | Cisapride | Cisapride 1件: Cisapride; | 2件: D00274 D00274
D02092 D02092 💬 |
3件: HTR2A, HTR3A, HTR4 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
64 | Citalopram | 20mg daily citalopram 8件: 20mg daily citalopram; Bupropion & citalopram; Citalopram; Citalopram 20mg; Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | 2件: D00822 D00822
D07704 D07704 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
65 | Cladribine | Cladribine 6件: Cladribine; Cladribine 3.5 mg/kg; Cladribine 5.25 mg/kg; Cladribine oral tablet; Cladribine tablet; Cladribine tablets; | 1件: D01370 D01370 💬 |
1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 2件: 13, 94 💬 |
66 | Clemastine | Clemastine 2件: Clemastine; Clemastine fumarate; | 2件: D00666 D00666
D03535 D03535 💬 |
1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
67 | Clenbuterol | Clenbuterol 3件: Clenbuterol; Clenbuterol hcl; Clenbuterol hydrochloride; | 1件: D07713 D07713 💬 |
1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 5件: 1 , 2 , 6 , 13, 256 💬 |
68 | Clostridium botulinum | Clostridium botulinum 2件: Clostridium botulinum; Clostridium botulinum toxin type a; | - |
- |
- |
013 1件: 13 💬 |
69 | Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - |
- |
- |
013 2件: 13, 46 💬 |
70 | Coconut | Coconut 4件: Coconut; Coconut oil; Coconut oil and epigallocatechin gallate; Other: natural herbs of coconut, aloe vera, and pepperint; | - |
- |
- |
013 2件: 13, 53 💬 |
71 | Coconut oil | Coconut oil 2件: Coconut oil; Coconut oil and epigallocatechin gallate; | 1件: D05326 D05326 💬 |
- |
- |
013 1件: 13 💬 |
72 | Coenzyme M | - | - |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
73 | Corticotropin | Adrenocorticotropin hormone 8件: Adrenocorticotropin hormone; Corticotropin; Corticotropin-releasing hormone; H.p. acthar gel (repository corticotropin injection); Other: corticotropin releasing hormone (crh); Ovine corticotropin-releasing hormone (ocrh); Repository corticotropin injection; Repository corticotropin injection -treatment extension; | 1件: D00146 D00146 💬 |
1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬 |
74 | Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | - | - |
- |
- |
013 2件: 13, 46 💬 |
75 | Cranberry | Cranberry 1件: Cranberry; | - |
- |
- |
013 1件: 13 💬 |
76 | Creatine | Creatine 4件: Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; | - |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
77 | Creatinolfosfate | - | 1件: D07162 D07162 💬 |
- |
- |
013 1件: 13 💬 |
78 | Curcumin | Bio-enhanced curcumin soft gelatin capsule 6件: Bio-enhanced curcumin soft gelatin capsule; Curcumin; Curcumin (longvida™); Curcumin supplement; Liposomed polyphenols resveratrol and curcumin; Nanocurcumin; | - |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
79 | Cyanocobalamin | - | 4件: D00166 D00166
D03615 D03615
D03616 D03616
D03617 D03617 💬 |
- |
- |
006 5件: 6 , 13, 201, 229, 299 💬 |
80 | Cyclophosphamide | Busulfan, cyclophosphamide, antithymocyte globulin 55件: Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Busulfan, cyclophosphamide, atg, gcsf; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Campath, fludarabine, cyclophosphamide; Cyclophosphamide; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide (cytoxan); Cyclophosphamide (drug); Cyclophosphamide + pred; Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide 50mg; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and atg; Cyclophosphamide and fludarabine; Cyclophosphamide and steroids; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclophosphamide injection 1g; Cyclophosphamide monohydrate; Cyclophosphamide post transplant; Cyclophosphamide(ctx); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide, bortezomib, and dexamethasone (cybord); Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Cyclophosphamide, fludarabine; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Cyclophosphamide-prednisone-azathioprine; Cyclophosphamide/glatiramer acetate; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; High-dose cyclophosphamide; Iv cyclophosphamide; Lenalidomide, dexamethasone and cyclophosphamide; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; Prednisone, cyclophosphamide; Prednisone, methylprednisolone,cyclophosphamides; Procedure: cyclophosphamide; Rituximab and cyclophosphamide iv; Thalidomide, cyclophosphamide and prednisone; | 2件: D00287 D00287
D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
81 | Cysteine | Acetylcysteine 17件: Acetylcysteine; Acetylcysteine effervescent tablets; Cysteine; Cysteine hydrochloride; Glatiramer acetate, n-acetylcysteine; Intravenous and oral n-acetyl cysteine; Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets; Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets; N acetyl cysteine; N acetylcysteine; N-acetyl cysteine; N-acetyl cysteine (nac); N-acetyl-cysteine; N-acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine capsule; N-acetylcysteine, (nac); | 2件: D00026 D00026
D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
82 | Cytarabine | Carmustine, etoposide, cytarabine, and melphalan (beam) 2件: Carmustine, etoposide, cytarabine, and melphalan (beam); Cytarabine; | 3件: D00168 D00168
D03046 D03046
D03637 D03637 💬 |
- |
- |
011 6件: 11, 13, 14, 25, 49, 60 💬 |
83 | Daclizumab | Biib019 (daclizumab high yield process) 10件: Biib019 (daclizumab high yield process); Biib019 (daclizumab); Daclizumab; Daclizumab (anti-cd25 humanized monoclonal antibody); Daclizumab high yield process; Daclizumab hyp; Daclizumab hyp (dac hyp; Daclizumab hyp (dac hyp); Daclizumab wih greek suffix; Daclizumab with greek suufix; | 1件: D03639 D03639 💬 |
1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 7件: 13, 56, 60, 65, 97, 283, 284 💬 |
84 | Dalfampridine | Dalfampridine 6件: Dalfampridine; Dalfampridine er; Dalfampridine-er 10mg; Dalfampridine-er 5mg; Other: withdrawal of dalfampridine-er 10mg; Sustained-release oral dalfampridine; | 1件: D04127 D04127 💬 |
4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 5件: 3 , 4 , 6 , 13, 14 💬 |
85 | Dantrolene | Dantrolene 2件: Dantrolene; Dantrolene sodium; | 2件: D02274 D02274
D02347 D02347 💬 |
- |
- |
013 2件: 13, 233 💬 |
86 | Dapirolizumab pegol | Dapirolizumab pegol 2件: Dapirolizumab pegol; Dapirolizumab pegol (dzp); | - |
- |
- |
013 2件: 13, 49 💬 |
87 | Darifenacin | Darifenacin 3件: Darifenacin; Darifenacin (bay79-4998); Oxybutynin and darifenacin; | 2件: D01699 D01699
D03654 D03654 💬 |
1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 2件: 6 , 13 💬 |
88 | Decitabine | Decitabine 1件: Decitabine; | 1件: D03665 D03665 💬 |
3件: DNMT1, DNMT3A, DNMT3B 💬 |
Cysteine and methionine metabolism 3件: Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer |
013 4件: 13, 63, 90, 301 💬 |
89 | Dexamethasone | Bortezomib/dexamethasone 48件: Bortezomib/dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Bupivacaine/epinephrine/dexamethasone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Control intervention (no dexamethasone); Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cyclophosphamide, bortezomib, and dexamethasone (cybord); Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Device: dexamethasone injection; Dexamethasone; Dexamethasone (1 cycle); Dexamethasone (4 cycles); Dexamethasone (50mg 1dd6, 3 consecutive days/month); Dexamethasone 0,1 mg tablets; Dexamethasone 0,5mg; Dexamethasone 0.5mg tablet; Dexamethasone 0.5mg/5ml solution; Dexamethasone 0.5mg/5ml solution in mucolox™; Dexamethasone 1,5 mg tablets; Dexamethasone 21-dihydrogen phosphate; Dexamethasone 21-phosphate; Dexamethasone 2mg tablets; Dexamethasone 4 mg jenapharm; Dexamethasone abcur; Dexamethasone and rituximab; Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland).; Dexamethasone parotid irrigation; Dexamethasone sodium phosphate; Dexamethasone sodium phosphate 250 mg/ 10 ml; Dexamethasone sodium phosphate 250 mg/10 ml solution; Dexamethasone sodium phosphate ph. eur.; Dexamethasone sodium sulfate; Dexamethasone soduim phosphate; Dexamethasone, 40 mg; Diagnostic test: dexamethasone test; High dose dexamethasone pulses; Intraarticular dexamethasone; Intravenous dexamethasone 1 mg; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Lenalidomide, dexamethasone and cyclophosphamide; Melphalan, thalidomide and dexamethasone; Mmf and dexamethasone; Peri-neural dexamethasone 1 mg; Pomalidomide and dexamethasone; Procedure: epidural steroid (dexamethasone) injection; | 9件: D00292 D00292
D00975 D00975
D01510 D01510
D01615 D01615
D01632 D01632
D01948 D01948
D02174 D02174
D02591 D02591
D02592 D02592 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
90 | Dexchlorpheniramine | Dexchlorpheniramine 1件: Dexchlorpheniramine; | 1件: D07803 D07803 💬 |
1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
91 | Dexrazoxane | Dexrazoxane 2件: Dexrazoxane; Dexrazoxane (drz) plus mitoxantrone (mx); | 1件: D03730 D03730 💬 |
2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
92 | Dextromethorphan | Dextromethorphan 10件: Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; | 3件: D00848 D00848
D03742 D03742
D03744 D03744 💬 |
6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
93 | Dextrose, unspecified form | - | - |
- |
- |
002 18件: 2 , 6 , 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
94 | Diazoxide | Diazoxide 3件: Diazoxide; Diazoxide choline; Diazoxide choline controlled-release tablet; | 1件: D00294 D00294 💬 |
2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 2件: 13, 193 💬 |
95 | Diclofenac | Comparator: diclofenac 8件: Comparator: diclofenac; Comparator: diclofenac sodium; Diclofenac; Diclofenac + omeprazole; Diclofenac 50 milligrams; Diclofenac sodium; Diclofenac sodium topical gel; Diclofenac sr; | 3件: D00903 D00903
D00904 D00904
D07816 D07816 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 34, 46, 271 💬 |
96 | Dimethyl fumarate | Dimethyl fumarate 5件: Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate 240 mg; Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate); | 1件: D03846 D03846 💬 |
1件: KEAP1 💬 |
Fluid shear stress and atherosclerosis 4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 4件: 13, 51, 86, 296 💬 |
97 | Dimethyltryptamine | - | - |
- |
- |
013 1件: 13 💬 |
98 | Diroximel fumarate | Diroximel fumarate 2件: Diroximel fumarate; Diroximel fumarate (drf); | 1件: D11154 D11154 💬 |
- |
- |
013 1件: 13 💬 |
99 | Dirucotide | Dirucotide 2件: Dirucotide; Dirucotide acetate; | 1件: D09396 D09396 💬 |
- |
- |
013 1件: 13 💬 |
100 | Domperidone | Domperidone 3件: Domperidone; Domperidone (drug); Levodopa and domperidone; | 2件: D01745 D01745
D07868 D07868 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 5件: 6 , 13, 17, 51, 230 💬 |
101 | Donepezil | Donepezil 7件: Donepezil; Donepezil hci (drug); Donepezil hydrochloride; Donepezil sandoz; Other: [11c]donepezil pet; Pridia (donepezil hydrochloride) 5mg; Prior donepezil 5mg; | 2件: D00670 D00670
D07869 D07869 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
102 | Doxycycline | Antimicrobial therapy: co-trimoxazole or doxycycline 10件: Antimicrobial therapy: co-trimoxazole or doxycycline; Doxycycline; Doxycycline 100 mg capsules; Doxycycline 100-200mg capsules daily for 6 months; Doxycycline hyclate; Doxycycline hyclate ph.eur; Doxycycline tablets; Interferon beta 1a, oral doxycycline; Other: no doxycycline; Treatment with systemic therapy (doxycycline); | 5件: D00307 D00307
D02129 D02129
D03903 D03903
D03904 D03904
D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
103 | Dronabinol | Cannabidiol / dronabinol capsule 5 mg+2,5 mg 5件: Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol; Dronabinol 25 mg/ml, oral drops; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg; | 1件: D00306 D00306 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 7件: 2 , 8 , 13, 46, 96, 271, 298 💬 |
104 | Dulaglutide | - | 1件: D09889 D09889 💬 |
1件: GLP1R 💬 |
Insulin secretion 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 1件: 13 💬 |
105 | Duloxetine | Duloxetine 3件: Duloxetine; Duloxetine hydrochloride; Duloxetine hydrochloride (hci); | 2件: D01179 D01179
D07880 D07880 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 2件: 6 , 13 💬 |
106 | Dydrogesterone | Dydrogesterone 1件: Dydrogesterone; | 1件: D01217 D01217 💬 |
1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 1件: 13 💬 |
107 | Eculizumab | Abp 959 - biosimilar to eculizumab 7件: Abp 959 - biosimilar to eculizumab; Abp 959 - proposed biosimilar to eculizumab; Eculizumab; Other: blood collection for measurement of eculizumab peak concentrations; Other: eculizumab; Sb12 (proposed eculizumab biosimilar); Soliris (eculizumab); | 1件: D03940 D03940 💬 |
1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 8件: 11, 13, 14, 61, 62, 109, 222, 223 💬 |
108 | Efalizumab | Efalizumab 1件: Efalizumab; | 1件: D03959 D03959 💬 |
1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
109 | Elezanumab | Elezanumab 1件: Elezanumab; | 1件: D11355 D11355 💬 |
1件: RGMA 💬 |
Axon guidance 2件: Axon guidance, TGF-beta signaling pathway |
013 1件: 13 💬 |
110 | Epigallocatechin | (2)-epigallocatechin-3-gallate (egcg) 7件: (2)-epigallocatechin-3-gallate (egcg); Coconut oil and epigallocatechin gallate; Epigallocatechin; Epigallocatechin gallate; Epigallocatechin-3-gallate (egcg); Epigallocatechin-gallate; Epigallocatechin-gallate (sunphenon); | - |
- |
- |
008 5件: 8 , 13, 28, 85, 113 💬 |
111 | Epigallocatechin gallate | Coconut oil and epigallocatechin gallate 2件: Coconut oil and epigallocatechin gallate; Epigallocatechin gallate; | - |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
112 | Erythropoietin | Erythropoietin 4件: Erythropoietin; Erythropoietin human recombinant (eporh); Recombinant human erythropoietin; Recombinant human erythropoietin(rhepo); | 1件: D03231 D03231 💬 |
1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 10件: 2 , 6 , 13, 18, 22, 46, 47, 70, 95, 96 💬 |
113 | Escitalopram | Escitalopram 4件: Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | 3件: D02567 D02567
D07704 D07704
D07913 D07913 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
002 3件: 2 , 6 , 13 💬 |
114 | Esomeprazole | Esomeprazole 3件: Esomeprazole; Esomeprazole 20 mg; Nexium (esomeprazole magnesium); | 4件: D01984 D01984
D04056 D04056
D07917 D07917
D09339 D09339 💬 |
2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 6件: 13, 46, 86, 98, 298, 299 💬 |
115 | Estradiol | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream 9件: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Estradiol; Estradiol 2 mg; Estradiol hemihydrate; Ethinyl estradiol; Ethinylestradiol; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg; | 8件: D00105 D00105
D01413 D01413
D01617 D01617
D01953 D01953
D04061 D04061
D04063 D04063
D04064 D04064
D04065 D04065 💬 |
2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 5件: 13, 46, 49, 226, 299 💬 |
116 | Estriol | Estriol 2件: Estriol; Vaginal estriol; | 2件: D00185 D00185
D01986 D01986 💬 |
2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 2件: 13, 227 💬 |
117 | Eszopiclone | Eszopiclone 1件: Eszopiclone; | 1件: D02624 D02624 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 3件: 6 , 13, 46 💬 |
118 | Ethanol | Andrographis paniculata (ethanol extract) 11件: Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate; Other: physalis angulata ethanol extract; Treprostinil diethanolamine; | 4件: D00068 D00068
D02798 D02798
D04855 D04855
D06542 D06542 💬 |
- |
- |
013 7件: 13, 51, 58, 97, 279, 280, 298 💬 |
119 | Ethinylestradiol | Ethinylestradiol 1件: Ethinylestradiol; | 1件: D00554 D00554 💬 |
1件: ESR1 💬 |
Breast cancer 8件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 4件: 13, 46, 49, 299 💬 |
120 | Etifoxine | Etifoxine 1件: Etifoxine; | 1件: D07320 D07320 💬 |
- |
- |
013 1件: 13 💬 |
121 | Etoposide | Carmustine, etoposide, cytarabine, and melphalan (beam) 2件: Carmustine, etoposide, cytarabine, and melphalan (beam); Etoposide; | 2件: D00125 D00125
D04107 D04107 💬 |
2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
122 | Evobrutinib | Evobrutinib 4件: Evobrutinib; Evobrutinib 10mg; Evobrutinib 25mg; M2951 (other name: evobrutinib); | - |
- |
- |
013 3件: 13, 46, 49 💬 |
123 | Famciclovir | Famciclovir 1件: Famciclovir; | 1件: D00317 D00317 💬 |
- |
- |
013 1件: 13 💬 |
124 | Febuxostat | Febuxostat 1件: Febuxostat; | 1件: D01206 D01206 💬 |
1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 3件: 2 , 6 , 13 💬 |
125 | Fenamole | - | 1件: D04139 D04139 💬 |
- |
- |
006 3件: 6 , 13, 160 💬 |
126 | Fenebrutinib | Fenebrutinib 1件: Fenebrutinib; | 1件: D11457 D11457 💬 |
1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
013 1件: 13 💬 |
127 | Ferric oxide | - | 1件: D04168 D04168 💬 |
- |
- |
013 1件: 13 💬 |
128 | Ferric pyrophosphate citrate | - | 1件: D10933 D10933 💬 |
- |
- |
013 1件: 13 💬 |
129 | Ferumoxytol | Ferumoxytol 1件: Ferumoxytol; | 1件: D04177 D04177 💬 |
- |
- |
013 1件: 13 💬 |
130 | Filgrastim | Ep2006 (filgrastim) 7件: Ep2006 (filgrastim); Filgrastim; Filgrastim (g-csf); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Pegfilgrastim; | 1件: D03235 D03235 💬 |
1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 33件: 2 , 6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
131 | Fingolimod | 0,5 mg fingolimod 9件: 0,5 mg fingolimod; Fingolimod; Fingolimod (fty720); Fingolimod 0.5 mg; Fingolimod 1.25 mg; Fingolimod hydrochloride; Fingolimodi; Hidrocloruro de fingolimod; Other: fingolimod; | 1件: D10001 D10001 💬 |
1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 14, 156 💬 |
132 | Firategrast | Firategrast 7件: Firategrast; Firategrast (usan approved name); Firategrast 150 mg; Firategrast 300 mg; Firategrast gastro-retentive solution; Firategrast immediate release tablet; Firategrast modified release tablet; | 1件: D06590 D06590 💬 |
1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
133 | Fish oil | Combination fish oil and borage seed oil 10件: Combination fish oil and borage seed oil; Combination of fish oil and colesevelam; Fish oil; Fish oil concentrate; Fish oil supplement; Fish oil, gamma-linolenic acid; Fish oil, rich in omega-3-acids; Fish oil,rich in omega 3 acids; Lipoic acid (la) with fish oil and la without fish oil; Omega-3 fatty acid fish oil supplement; | - |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
134 | Florbetapir (18F) | Florbetapir 18f 2件: Florbetapir 18f; Florbetapir 18f injection; | 1件: D09617 D09617 💬 |
- |
- |
013 2件: 13, 127 💬 |
135 | Fludarabine | Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) 24件: Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Busulfan, fludarabine and atg; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan, fludarabine, atg, tli; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide and fludarabine; Cyclophosphamide, fludarabine; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Fludarabine; Fludarabine (flu); Fludarabine monophosphate; Fludarabine phosphate; Fludarabine phosphate 30 mg; Fludarabine phosphate 40 mg; Fludarabine, busulfan, thymoglobulin; Fludarabine, cyclophosphamide; Fludarabine, melphalan, thiotepa; Fludarabine/ melphalan; Fludarabine/busulfan; Sq fludarabine; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; | 2件: D01907 D01907
D07966 D07966 💬 |
1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 18件: 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
136 | Fludeoxyglucose (18F) | - | - |
- |
- |
005 13件: 5 , 6 , 7 , 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
137 | Flumazenil | 11c-flumazenil 7件: 11c-flumazenil; Diagnostic test: pet with [11c]flumazenil; Flumazenil; Pet with 11c-flumazenil; Transdermal flumazenil (added 4/2020); [11c]flumazenil; [18f]flumazenil; | 1件: D00697 D00697 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 5件: 6 , 13, 17, 18, 206 💬 |
138 | Fluoxetine | Amitriptyline, fluoxetine and tramadol alone (control group) 4件: Amitriptyline, fluoxetine and tramadol alone (control group); Fluoxetine; Fluoxetine hydrochloride; Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group); | 2件: D00326 D00326
D00823 D00823 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
013 6件: 13, 17, 78, 86, 179, 206 💬 |
139 | Flupirtine | Flupirtine 1件: Flupirtine; | 1件: D07978 D07978 💬 |
- |
- |
013 1件: 13 💬 |
140 | Flurbiprofen | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 3件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Flurbiprofen; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | 3件: D00330 D00330
D01475 D01475
D02290 D02290 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 3件: 13, 21, 46 💬 |
141 | Folic acid | Folic acid 5件: Folic acid; Folic acid or folate; Folic acid, vitamin b6, vitamin b12; Methotrexate and folic acid; Rituximab, mtx, folic acid; | 1件: D00070 D00070 💬 |
- |
- |
006 5件: 6 , 13, 46, 49, 84 💬 |
142 | Fumaric Acid | Fumaric acid 2件: Fumaric acid; Second-generation fumaric acid; | 1件: D02308 D02308 💬 |
- |
- |
013 1件: 13 💬 |
143 | Gabapentin | Gabapentin 9件: Gabapentin; Gabapentin prescriptions; Gabapentina; Gabapentina kern pharma; Gabapentine; Gabapentine 300mg; Multi-modal pain management [acetaminophen + gabapentin]; Multi-modal pain management [valium + gabapentin]; Transdermal fentanyl matrix, gabapentin; | 1件: D00332 D00332 💬 |
5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
144 | Gadobenic acid | - | 2件: D04283 D04283
D08018 D08018 💬 |
- |
- |
013 3件: 13, 86, 88 💬 |
145 | Gadobutrol | Gadobutrol 2件: Gadobutrol; Other: gadobutrol; | 1件: D07420 D07420 💬 |
- |
- |
013 3件: 13, 22, 46 💬 |
146 | Gadolinium | Device: magnetic resonance imaging (mri) with gadolinium enhancement 10件: Device: magnetic resonance imaging (mri) with gadolinium enhancement; Device: magnetic resonance imaging (mri) without gadolinium enhancement; Diagnostic test: cardiac mri (gadolinium enhanced); Gadolinium; Gadolinium contrast; Gadolinium for abdomen; Gadolinium for lower back; Gadolinium-based contrast; Other: uspio mri - gadolinium mri; Standard gadolinium contrast; | - |
- |
- |
013 6件: 13, 34, 46, 58, 65, 86 💬 |
147 | Gadopentetic acid | - | 2件: D01707 D01707
D08006 D08006 💬 |
- |
- |
013 2件: 13, 34 💬 |
148 | Gadoteric acid | Gadoteric acid 1件: Gadoteric acid; | 1件: D08007 D08007 💬 |
- |
- |
013 2件: 13, 53 💬 |
149 | Gadoteridol | Gadoteridol 2件: Gadoteridol; Prohance (gadoteridol); | 1件: D01137 D01137 💬 |
- |
- |
013 1件: 13 💬 |
150 | gamma-Tocopherol | Gamma-tocopherol 1件: Gamma-tocopherol; | - |
- |
- |
013 1件: 13 💬 |
151 | Gamolenic acid | - | 1件: D07213 D07213 💬 |
- |
- |
013 3件: 13, 19, 46 💬 |
152 | Ginkgo biloba | Ginkgo biloba 3件: Ginkgo biloba; Ginkgo biloba pills sig: 300mg/tid; Standardized ginkgo biloba extract (egb 761 (r); | - |
- |
- |
006 4件: 6 , 13, 18, 90 💬 |
153 | Ginseng | American ginseng 4件: American ginseng; American ginseng extract ht-1001; Ginseng; Korean red ginseng; | 1件: D06772 D06772 💬 |
- |
- |
013 3件: 13, 46, 53 💬 |
154 | Glatiramer | 20mg/0.5ml glatiramer acetate 29件: 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 40 mg glatiramer acetato; Cyclophosphamide/glatiramer acetate; Experimental glatiramer acetate; Glatiramer; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Glatiramer acetato; Glatiramero acetato; Human interferon beta-1a and glatiramer acetate; Procedure: warm compress prior to injection of glatiramer acetate; | 1件: D04318 D04318 💬 |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 4件: 2 , 13, 96, 156 💬 |
155 | Glycerin | Glycerine 2件: Glycerine; Other: glycerine gel; | 1件: D00028 D00028 💬 |
- |
- |
006 6件: 6 , 13, 79, 265, 316, 317 💬 |
156 | Gold | Gold 7件: Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); | - |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
157 | GSK-2018682 | Gsk2018682 5件: Gsk2018682; Gsk2018682 cd2 capsule; Gsk2018682 cd3 micronised tablet; Gsk2018682 cd3 non-micronised tablet; Gsk2018682 cd3 non-micronised tablet in fed state; | - |
- |
- |
013 1件: 13 💬 |
158 | GSK-239512 | Gsk239512 1件: Gsk239512; | - |
- |
- |
013 1件: 13 💬 |
159 | Guanabenz | Guanabenz 2件: Guanabenz; Guanabenz acetato; | 1件: D04375 D04375 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 2件: 2 , 13 💬 |
160 | Histamine | Antihistamine 3件: Antihistamine; Histamine; Other: histamine; | 1件: D08040 D08040 💬 |
4件: HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
161 | Histidine | Copper histidine 3件: Copper histidine; Histidine; L-histidine; | 1件: D00032 D00032 💬 |
- |
- |
013 3件: 13, 169, 170 💬 |
162 | Human C1-esterase inhibitor | - | - |
- |
- |
013 3件: 13, 61, 65 💬 |
163 | Human immunoglobulin G | Human immunoglobulin g 2件: Human immunoglobulin g; Normal human immunoglobulin g; | - |
- |
- |
011 11件: 11, 13, 14, 17, 35, 43, 45, 50, 51, 63, 65 💬 |
164 | Human interferon beta | Human interferon beta 6件: Human interferon beta; Human interferon beta 1a (rebif); Human interferon beta-1a and glatiramer acetate; New formulation of rebif - human interferon beta-1a; Recombinant human interferon beta; Recombinant human interferon beta-1a; | - |
- |
- |
013 5件: 13, 20, 26, 96, 97 💬 |
165 | Human interleukin-2 | Anti-human interleukin-23 monoclonal antibody 3件: Anti-human interleukin-23 monoclonal antibody; Human interleukin-2; Recombinant human interleukin-2 (rhil-2); | - |
- |
- |
002 17件: 2 , 13, 35, 46, 49, 51, 53, 55, 56, 60, 63, 65, 95, 96, 97, 162, 271 💬 |
166 | Human Umbilical Cord Mesenchymal Stem Cells | Human umbilical cord mesenchymal stem cells 1件: Human umbilical cord mesenchymal stem cells; | - |
- |
- |
002 12件: 2 , 13, 36, 46, 49, 51, 60, 96, 97, 113, 274, 284 💬 |
167 | Hydrochlorothiazide | Hydrochlorothiazide 2件: Hydrochlorothiazide; Hydrochlorothiazide/amiloride; | 1件: D00340 D00340 💬 |
- |
- |
013 4件: 13, 67, 225, 235 💬 |
168 | Hydrogen | 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate 8件: 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate; Hydrocortisone hydrogen succinate; Hydrogen; Hydrogen peroxide; Lisuride hydrogenmaleate; Methylprednisolon-21-hydrogensuccinat, natriumsalz; Other: hydrogen peroxide; Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt); | - |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
169 | Hydrogen peroxide | Hydrogen peroxide 2件: Hydrogen peroxide; Other: hydrogen peroxide; | 1件: D00008 D00008 💬 |
- |
- |
013 1件: 13 💬 |
170 | Hydroxychloroquine | Hydroxychloroquine 19件: Hydroxychloroquine; Hydroxychloroquine (z0188); Hydroxychloroquine + prednisone; Hydroxychloroquine high; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Hydroxychloroquine sulfate; Hydroxychloroquine sulphate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Other: hydroxychloroquine/chloroquine; Plaquenil - hydroxychloroquine 200mg film coated tablets; Sirolimus and hydroxychloroquine 200 mg; Sirolimus and hydroxychloroquine 400 mg; Sulphasalazine + hydroxychloroquine or prednisolone; Versus hydroxychloroquine; | 1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
171 | Hydroxytyrosol | Essential - hydroxytyrosol 2件: Essential - hydroxytyrosol; Hydroxytyrosol; | - |
- |
- |
013 1件: 13 💬 |
172 | Hydroxyurea | Hydroxyurea 1件: Hydroxyurea; | 1件: D00341 D00341 💬 |
1件: RRM2 💬 |
Drug metabolism - other enzymes 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 8件: 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
173 | Ibudilast | Ibudilast 1件: Ibudilast; | 1件: D01385 D01385 💬 |
8件: CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬 |
Apelin signaling pathway 16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 2件: 2 , 13 💬 |
174 | Ibuprofen | Ibuprofen 6件: Ibuprofen; Ibuprofen 200mg; Ibuprofen sandoz 400 mg filmtabletten; Other: ibuprofen and isosorbide dinitrate combination; Rebif new formulation + ibuprofen prn; Rebif new formulation + prophylactic ibuprofen; | 4件: D00126 D00126
D01122 D01122
D04490 D04490
D06606 D06606 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 6件: 13, 46, 65, 113, 271, 299 💬 |
175 | Idebenone | Idebenone 2件: Idebenone; Idebenone 150 mg film-coated tablets; | 1件: D01750 D01750 💬 |
- |
- |
006 5件: 6 , 13, 18, 113, 302 💬 |
176 | Imatinib | Bevacizumab (avastin) and imatinib mesylate (gleevec) 7件: Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib; Imatinib mesilate; Imatinib mesilato; Imatinib mesylate; Imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule; | 2件: D01441 D01441
D08066 D08066 💬 |
3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
177 | Indian frankincense | - | - |
- |
- |
013 1件: 13 💬 |
178 | Inebilizumab | Inebilizumab 1件: Inebilizumab; | 1件: D11757 D11757 💬 |
1件: CD19 💬 |
B cell receptor signaling pathway 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency |
011 3件: 11, 13, 300 💬 |
179 | Inosine | 1) inosine 5'-monophosphate 2件: 1) inosine 5'-monophosphate; Inosine; | 1件: D00054 D00054 💬 |
- |
- |
002 5件: 2 , 6 , 13, 17, 85 💬 |
180 | Interferon alfa | Interferon alfa 5件: Interferon alfa; Interferon alfa-2a; Interferon alfa-2b; Pegylated interferon alfa; Recombinant interferon alfa; | 1件: D03305 D03305 💬 |
2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 6件: 13, 25, 26, 28, 56, 96 💬 |
181 | Interferon beta-1a | Avonex (interferon beta-1a), biogen idec ltd 32件: Avonex (interferon beta-1a), biogen idec ltd; Bg9418 (interferon beta-1a); Biib017 (peginterferon beta-1a); Device: biib017 (peginterferon beta-1a) autoinjector; Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs); Device: interferon beta-1a; Human interferon beta-1a and glatiramer acetate; Interferon beta-1a; Interferon beta-1a (avonex); Interferon beta-1a (avonex®); Interferon beta-1a (current approved manufacturing process invloving fbs); Interferon beta-1a (new process, manufactured without fbs); Interferon beta-1a (rebif); Interferon beta-1a (rebif®) alone; Interferon beta-1a 30 µg; Interferon beta-1a fbs-free/hsa free, rnf; Interferon beta-1a fbs-free/hsa-free; Interferon beta-1a fbs-free/hsa-free, rnf; Interferon beta-1a hsa+ biosimilar; Interferon beta-1a hsa-free biosimilar; Interferon beta-1a original; Interferon beta-1a, 30 µg/0.5 ml; New formulation of rebif - human interferon beta-1a; Peginterferon beta-1a; Pegylated interferon beta-1a; Plegridy (peginterferon beta-1a), biogen idec ltd; Rebif (interferon beta-1a); Rebif (interferon beta-1a), merck serono europe ltd; Recombinant human interferon beta-1a; Sc interferon beta-1a; Sc peginterferon beta-1a; Vigantol oil plus interferon beta-1a (rebif); | 1件: D04554 D04554 💬 |
2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 4件: 13, 26, 96, 97 💬 |
182 | Interferon beta-1b | Betaferon® (interferon beta-1b) 21件: Betaferon® (interferon beta-1b); Betaseron (interferon beta-1b, bay86-5046); Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag; Extavia (interferon beta-1b), novartis pharma ag; Interferon beta-1b; Interferon beta-1b (betaferon, bay 86-5046); Interferon beta-1b (betaferon, bay86-5046); Interferon beta-1b (betaferon/betaseron, bay86-5046); Interferon beta-1b (betaferon®, bay 86-5046); Interferon beta-1b (betaseron, bay86-5046); Interferon beta-1b (betaseron, betaferon, bay86-5046); Interferon beta-1b (pf530, betaferon); Interferon beta-1b and tacrolimus; Interferon beta-1b group; Interferon beta-1b, (betaseron bay86-5046); Interferon beta-1b, frp about 6 weeks after randomization; Interferon beta-1b, frp within 15 days after randomization; Interferon beta-1b/atorvastatin group; Msdmds other than betaseron (interferon beta-1b, bay86-5046); Recombinant interferon beta-1b; Sc interferon beta-1b; | 1件: D00746 D00746 💬 |
2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
183 | IR208 | - | - |
- |
- |
013 1件: 13 💬 |
184 | Isoxaflutole | - | - |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
185 | Isoxsuprine | Isoxsuprine 2件: Isoxsuprine; Isoxsuprine hydrochloride; | 1件: D08092 D08092 💬 |
1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
186 | Ixazomib | Ixazomib 3件: Ixazomib; Ixazomib (ninlaro®) capsules; Ixazomib citrate; | 1件: D10130 D10130 💬 |
1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 4件: 13, 16, 28, 61 💬 |
187 | Josamycin | - | 1件: D01235 D01235 💬 |
- |
- |
006 2件: 6 , 13 💬 |
188 | Ketamine | Esketamine 6件: Esketamine; Esketamine hydrochloride; Ketamine; Multi-modal pain management [intravenous ketamine]; S-ketamine; S-ketamine & midazolam; | 2件: D00711 D00711
D08098 D08098 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 8件: 2 , 4 , 6 , 13, 70, 113, 156, 215 💬 |
189 | Ketoconazole | 2s,4r-(-)-ketoconazole 5件: 2s,4r-(-)-ketoconazole; 2s,4r-(-)-ketoconazole, levoketoconazole; Dimebon + ketoconazole; Ketoconazole; Levoketoconazole; | 1件: D00351 D00351 💬 |
1件: CYP17A1 💬 |
Cortisol synthesis and secretion 6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 3件: 8 , 13, 75 💬 |
190 | keyhole limpet hemocyanin | Keyhole limpet hemocyanin 3件: Keyhole limpet hemocyanin; Keyhole limpet hemocyanin (klh); Keyhole limpet hemocyanin (klh) neo-antigen; | - |
- |
- |
013 2件: 13, 46 💬 |
191 | L-Lysine | L-lysine 6件: L-lysine; L-lysine n acetylcysteinate; L-lysine n-acetylcysteinate; L-lysine- n-acetylcysteinate; L-lysine-n-acetyl-l-cysteinate; L-lysine-n-acetylcysteinate; | 1件: D02304 D02304 💬 |
- |
- |
013 5件: 13, 19, 97, 228, 299 💬 |
192 | Lactose | 2'-fucosyllactose 4件: 2'-fucosyllactose; Lactose; Lactose in water; Lactose monohydrate; | 2件: D00046 D00046
D03226 D03226 💬 |
- |
- |
002 6件: 2 , 6 , 13, 97, 228, 310 💬 |
193 | Lamotrigine | Lamotrigine 4件: Lamotrigine; Lamotrigine - generic product; Lamotrigine dispers; Lamotrigine extended release tablets; | 1件: D00354 D00354 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 5件: 13, 34, 38, 114, 144 💬 |
194 | Laquinimod | Cápsulas de laquinimod 0.6 mg 12件: Cápsulas de laquinimod 0.6 mg; Laquinimod; Laquinimod 0.3; Laquinimod 0.6; Laquinimod 1.2; Laquinimod capsulas 0.6 mg; Laquinimod capsules 0.3 mg; Laquinimod capsules 0.5 mg; Laquinimod capsules 0.6 mg; Laquinimod cápsulas 0.5 mg; Laquinimod sodium (usan); Laquinimod tablets 0.3 mg; | - |
- |
- |
008 4件: 8 , 13, 49, 96 💬 |
195 | Lenograstim | Granocyte - 34 million iu (lenograstim rhug-csf) 3件: Granocyte - 34 million iu (lenograstim rhug-csf); Granocyte lenograstim; Lenograstim; | 1件: D03247 D03247 💬 |
1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 7件: 2 , 13, 16, 18, 19, 57, 65 💬 |
196 | Levetiracetam | Levetiracetam 1件: Levetiracetam; | 1件: D00709 D00709 💬 |
1件: SV2A 💬 |
ECM-receptor interaction 1件: ECM-receptor interaction |
002 4件: 2 , 4 , 6 , 13 💬 |
197 | Levocarnitine | Levocarnitine 4件: Levocarnitine; Levocarnitine propyl hydrochloride; Valproate, levocarnitine; Valproic acid and levocarnitine; | 3件: D02030 D02030
D02176 D02176
D04713 D04713 💬 |
- |
- |
003 10件: 3 , 5 , 13, 53, 58, 96, 97, 265, 298, 316 💬 |
198 | Levoleucovorin | - | 1件: D04715 D04715 💬 |
- |
- |
013 1件: 13 💬 |
199 | Levonorgestrel | Levonorgestrel 1件: Levonorgestrel; | 1件: D00950 D00950 💬 |
1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 1件: 13 💬 |
200 | Lidocaine | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream 11件: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Heparin & alkalinized lidocaine bladder instillation; Lidocaine; Lidocaine 1% injectable solution; Lidocaine 2% without vessel constrictor; Lidocaine injection 2%; Lidocaine patch 5%; Lidocaine releasing intravesical system - liris®; Local anesthesia (lidocaine hydrochloride); | 3件: D00358 D00358
D02086 D02086
D08127 D08127 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 12件: 6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬 |
201 | Linoleic acid | Linoleic acid 3件: Linoleic acid; Linoleic acid supplementation; Linoleic acid/oleic acid; | - |
- |
- |
006 6件: 6 , 13, 75, 76, 222, 299 💬 |
202 | Liothyronine | Liothyronine 3件: Liothyronine; Liothyronine i 131; Liothyronine sodium; | 2件: D01011 D01011
D08128 D08128 💬 |
2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
013 4件: 13, 78, 210, 212 💬 |
203 | Lipoic acid | Alpha lipoic acid 9件: Alpha lipoic acid; Alpha-lipoic acid; Alpha-lipoic acid and l-acetyl carnitine; Lipoic acid; Lipoic acid (la) with fish oil and la without fish oil; Lipoic acid and omega-3 fatty acids; Lipoic acid group; Oral lipoic acid (la); R lipoic acid; | 2件: D00048 D00048
D00086 D00086 💬 |
- |
- |
002 5件: 2 , 5 , 13, 14, 20 💬 |
204 | Lisdexamfetamine | Lisdexamfetamine 2件: Lisdexamfetamine; Lisdexamfetamine sulfate; | 1件: D08130 D08130 💬 |
2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 1件: 13 💬 |
205 | Lithium carbonate | Lithium carbonate 1件: Lithium carbonate; | 1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
206 | Loperamide | Loperamide 2件: Loperamide; Loperamide hydrochloride; | 3件: D00729 D00729
D07113 D07113
D08144 D08144 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 2件: 13, 97 💬 |
207 | Loratadine | Loratadine 1件: Loratadine; | 1件: D00364 D00364 💬 |
1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 3件: 13, 46, 98 💬 |
208 | Lubiprostone | Lubiprostone 1件: Lubiprostone; | 1件: D04790 D04790 💬 |
1件: CLCN2 💬 |
Mineral absorption 1件: Mineral absorption |
006 4件: 6 , 13, 290, 299 💬 |
209 | Magnesium | (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide 19件: (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; Magnesium; Magnesium aspartate; Magnesium aspartate hydrochloride; Magnesium citrate; Magnesium gluconate; Magnesium hydroxide; Magnesium oxide; Magnesium sulfate; Magnesium with ropivacaine; Mineral boost (magnesium); Nexium (esomeprazole magnesium); Omeprazole magnesium; Saroglitazar magnesium 2 mg; Saroglitazar magnesium 4 mg; Sodium picosulfate, magnesium oxide and citric acid; Sodium picosulfate/magnesium citrate laxative; Sulfate, magnesium; | - |
- |
- |
006 17件: 6 , 11, 13, 46, 51, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
210 | Maltodextrin | Maltodextrin 3件: Maltodextrin; Maltodextrin fiber supplement; Resistant maltodextrin; | 1件: D02329 D02329 💬 |
- |
- |
006 4件: 6 , 13, 96, 97 💬 |
211 | Mangafodipir | Mangafodipir 3件: Mangafodipir; Mangafodipir (teslascan); Other: mangafodipir trisodium; | 1件: D08262 D08262 💬 |
- |
- |
013 2件: 13, 58 💬 |
212 | Mannose | D mannose 5件: D mannose; Mannose; Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan; Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa); Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan avalglucosidase alfa (neogaa); | - |
- |
- |
013 2件: 13, 256 💬 |
213 | Masitinib | Masitinib 12件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib (ab1010); Masitinib 100 mg tablets; Masitinib 100mg; Masitinib 200 mg tablets; Masitinib 200mg; Masitinib 3 mg; Masitinib 6.0 mg; Masitinib mesylate; | 1件: D10229 D10229 💬 |
1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
214 | Medical Cannabis | - | - |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
215 | Melatonin | 3 mg melatonin 11件: 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin cr; Melatonin pr; Melatonin(circadin®); Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.; | 1件: D08170 D08170 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
216 | Melphalan | Carmustine, etoposide, cytarabine, and melphalan (beam) 10件: Carmustine, etoposide, cytarabine, and melphalan (beam); Fludarabine, melphalan, thiotepa; Fludarabine/ melphalan; Melphalan; Melphalan fulfenamide hydrochloride; Melphalan hydrochloride; Melphalan, thalidomide and dexamethasone; Melphalan-flufenamide (melflufen); Propylene glycol-free melphalan hydrochloride; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; | 1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
217 | Memantine | Memantine 5件: Memantine; Memantine (drug); Memantine (ebixa); Memantine hydrochloride; Memantine hydrochloride oral solution; | 2件: D04905 D04905
D08174 D08174 💬 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 7件: 2 , 6 , 8 , 13, 49, 127, 205 💬 |
218 | Metformin | 750 mg metformin and 7.5 g l-citrulline daily p.o. 21件: 750 mg metformin and 7.5 g l-citrulline daily p.o.; Glucophage (metformin); L-citrulline and metformin & l-citrulline; Metformin; Metformin (generic); Metformin 500mg; Metformin and metformin & l-citrulline; Metformin hcl; Metformin hydrochloride; Metformin treatment; Metformin/cp-690,550; Metformina; Metformina - 500 30 compresse 500 mg; Metformine; Metformine arrow 500mg; Metformine hcl 500 pch; Metformine sandoz 850 mg filmomhulde tabletten; Other: metformin; Pioglitazone or metformin; Sitagliptin and metformin; [metformina]; | 2件: D00944 D00944
D04966 D04966 💬 |
2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
219 | Methamidophos | - | - |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
220 | Methotrexate | Abatacept (aba) + methotrexate (mtx), double-blind (db) 113件: Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept + methotrexate; Adalimumab with methotrexate; Azathioprine or methotrexate; Bms-582949 and methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Certolizumab pegol + methotrexate (mtx); Clobetasol propionate + methotrexate; Combination product: methotrexate; Cp-690,550 + methotrexate; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclosporin, methotrexate (gvhd prophylaxis); Dmards (methotrexate; Early immunosuppressants (azathioprine, methotrexate); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept, methotrexate and depomedrone; Etanercept, methotrexate, prednisolone; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Infliximab + methotrexate (mtx); Infliximab, methylprednisolone, methotrexate; Intrathecal methotrexate; Methotrexate; Methotrexate 'lederle' 2,5mg tablets; Methotrexate 'lederle' 2.5mg tablets; Methotrexate 'lederle' tablets; Methotrexate (metoject® prefilled pen); Methotrexate (mtx); Methotrexate (stable dose); Methotrexate (tapering dose); Methotrexate + biologic administration; Methotrexate + infliximab; Methotrexate + methylprednisolone; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate - amneal; Methotrexate - dava; Methotrexate - delay; Methotrexate - etanercept - prednisolone arm; Methotrexate - immediate; Methotrexate 10 mg; Methotrexate 10 mg tablets; Methotrexate 2.5 mg; Methotrexate 2.5 mg tablets; Methotrexate 2.5mg tablets; Methotrexate 2.5mg tablets bp; Methotrexate 25 mg; Methotrexate 50mg/ml solution for injection, pre-filled syringe; Methotrexate ``lederle`` 2.5mg tablets; Methotrexate and folic acid; Methotrexate as methotrexate disodium; Methotrexate bellon; Methotrexate bellon 25mg/ml; Methotrexate capsules; Methotrexate disodium; Methotrexate ebewe; Methotrexate hospira 2,5 mg tablety; Methotrexate hospira 2.5 mg tablety; Methotrexate injection; Methotrexate lachema 5inj. sol; Methotrexate lederle 2.5 mg tablets; Methotrexate pfizer 2,5 mg tabletter; Methotrexate placebo; Methotrexate plus enbrel or enbrel alone; Methotrexate plus erb-041 for 12 weeks; Methotrexate plus sulfasalazine; Methotrexate pre-filled pen; Methotrexate prefilled pen; Methotrexate prefilled syringe; Methotrexate sodium; Methotrexate sodium 2.5mg tablets; Methotrexate sodium tablets 2.5 mg; Methotrexate sodium tablets 2.5mg; Methotrexate tablets; Methotrexate tablets 2.5 mg; Methotrexate treatment; Methotrexate wyeth 2,5mg; Methotrexate wyeth 2,5mg tbl.; Methotrexate ® 2.5mg tablets; Methotrexate(mtx); Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol; Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.; Methotrexate(necessary); Methotrexate*100cpr 2,5mg; Methotrexate*10mg/1,33ml 4s; Methotrexate*15mg/2ml 4sir; Methotrexate*2,5mg 25cpr; Methotrexate*20mg/2,66ml 4s; Methotrexate*25cpr 2,5mg; Methotrexate*7,5mg/ml 4sir.; Methotrexate, leucovorin and bms-986142; Methotrexate,adalimumab; Methotrexate-lachema; Methotrexate-sulfasalazine-hydroxychloroquine; Methotrexate® 2.5 mg tablets; Mp-435(dose1) + methotrexate; Mycophenolate mofetil,methotrexate; Oral methotrexate; Other: methotrexate therapy; Phase 1: methotrexate; Response to anakinra associated with methotrexate; Response to infliximab associated with methotrexate; Stable weekly dose of methotrexate; Tacrolimus with methotrexate; Tak-715 and methotrexate; Tak-783 and methotrexate; Tasocitinib plus methotrexate; Tocilizumab + methotrexate(mtx); Tocilizumab plus methotrexate; Tocilizumab+methotrexate(mtx); Tofacitinib with methotrexate; Tofacitinib without methotrexate; Treatment with systemic therapy (methotrexate); Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level; | 2件: D00142 D00142
D02115 D02115 💬 |
2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
221 | Methylphenidate | D-methylphenidate 11件: D-methylphenidate; Methylphenidate; Methylphenidate (mpd); Methylphenidate (overencapsulated); Methylphenidate 10mg tablets; Methylphenidate hydrochloride; Methylphenidate modified release; Methylphenidate modified release 20 mg; Methylphenidate modified release 30 mg; Methylphenidate modified release 40 mg; Methylphenidate, fluoxetin, risperidone; | 2件: D01296 D01296
D04999 D04999 💬 |
2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 7件: 6 , 13, 34, 84, 113, 179, 206 💬 |
222 | Methylprednisolone | Administration of rituximab and methylprednisolone 35件: Administration of rituximab and methylprednisolone; Corticosteroid treatment (methylprednisolone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; | 6件: D00407 D00407
D00751 D00751
D00979 D00979
D05000 D05000
D05001 D05001
D05002 D05002 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
223 | Methylprednisolone hemisuccinate | Methylprednisolone hemisuccinate 1件: Methylprednisolone hemisuccinate; | 1件: D05000 D05000 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
224 | Midazolam | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 7件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Midazolam; Midazolam 2 mg; Midazolam 3 mg; Midazolam injection; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; | 3件: D00550 D00550
D00696 D00696
D05028 D05028 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
225 | Minocycline | Combination of minocycline and mtx or mtx alone 8件: Combination of minocycline and mtx or mtx alone; Glatiramer acetate with minocycline; Lovastatin, then minocycline/lovastatin; Minocycline; Minocycline 100 mg film-coated tablets; Minocycline 100mg; Minocycline hydrochloride; Minocycline, then minocycline/lovastatin; | 2件: D00850 D00850
D05045 D05045 💬 |
- |
- |
002 14件: 2 , 6 , 8 , 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
226 | Mirabegron | Mirabegron 1件: Mirabegron; | 1件: D09535 D09535 💬 |
1件: ADRB3 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway |
006 3件: 6 , 13, 226 💬 |
227 | Mitoquinone | Mitoquinone 1件: Mitoquinone; | - |
- |
- |
006 3件: 6 , 13, 97 💬 |
228 | Mitoxantrone | Dexrazoxane (drz) plus mitoxantrone (mx) 4件: Dexrazoxane (drz) plus mitoxantrone (mx); Glatiramer acetate 20 mg, with mitoxantrone; Mitoxantrone; Other: mitoxantrone - immunomodulator; | 2件: D02166 D02166
D08224 D08224 💬 |
2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
229 | MK-0812 | Mk0812 2件: Mk0812; Mk0812 / duration of treatment: 12 weeks; | - |
- |
- |
013 2件: 13, 46 💬 |
230 | Modafinil | Armodafinil 5件: Armodafinil; Modafinil; Modafinil 50mg; Over-encapsulated modafinil; Provigil (modafinil); | 1件: D01832 D01832 💬 |
- |
- |
006 4件: 6 , 13, 49, 93 💬 |
231 | Monomethyl fumarate | Monomethyl fumarate 2件: Monomethyl fumarate; Monomethyl fumarate 190 mg; | 1件: D11492 D11492 💬 |
- |
- |
013 13件: 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
232 | Montelukast | 5 mg montelukast 8件: 5 mg montelukast; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast; Montelukast sodium; Montelukast teva; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; Montelukast/ singulair; Singulair (montelukast sodium); | 2件: D00529 D00529 < |